HDAC-targeting epigenetic modulators for cancer immunotherapy
B Cheng, W Pan, Y Xiao, Z Ding, Y Zhou, X Fei… - European Journal of …, 2024 - Elsevier
HDAC inhibitors, which can inhibit the activity of HDAC enzymes, have been extensively
studied in tumor immunotherapy and have shown potential therapeutic effects in cancer …
studied in tumor immunotherapy and have shown potential therapeutic effects in cancer …
The role of targeting CDK4/6 in cancer immunotherapy
M Sun, L Dong, Y Wang, C Liu, J Du, B Wang… - Holistic Integrative …, 2024 - Springer
Abstract Cyclin-dependent kinase 4/6 (CDK4/6) acts as a crucial point of regulation in the G1-
to-S transition in the cell division cycle, its aberrant activation was found in various human …
to-S transition in the cell division cycle, its aberrant activation was found in various human …
FGFR1 signaling facilitates obesity-driven pulmonary outgrowth in metastatic breast cancer
E Kulkoyluoglu Cotul, MH Safdar, SJ Paez… - Molecular Cancer …, 2024 - AACR
Survival of dormant, disseminated breast cancer cells contributes to tumor relapse and
metastasis. Women with a body mass index greater than 35 have an increased risk of …
metastasis. Women with a body mass index greater than 35 have an increased risk of …
[PDF][PDF] SHP-2 在肿瘤相关巨噬细胞中的研究进展
武雪亮， 樊建春， 郭飞， 张琦， 薛军， 王西墨… - 中国比较医学 …, 2024 - zgbjyx.cnjournals.com
肿瘤相关巨噬细胞(TAMs) 是肿瘤免疫微环境(TIME) 中的优势细胞群, 是TIME
中免疫系统抑制和肿瘤细胞增殖最重要的调节细胞. Src 同源2 蛋白酪氨酸磷酸酶2 (SHP-2) …
中免疫系统抑制和肿瘤细胞增殖最重要的调节细胞. Src 同源2 蛋白酪氨酸磷酸酶2 (SHP-2) …